Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): An overview of presentation and pathogenesis and guidelines for pathological diagnosis and management
Histopathology Jun 13, 2019
Jones JL, et al. - Via 518 cases recorded across 25 countries through the plastic surgeons PROFILE registry to provide standard guidelines for the diagnosis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL, a rare but important complication of breast implants), the contributors set to review the knowledge of the incidence of the disease, current thoughts on pathogenesis, patterns of presentation, and it's pathological features. However, characterized by CD30 positive neoplastic cells, BIA-ALCL should be interpreted with care, according to the provided pathological guidelines for the robust diagnosis of this lesion, as well as the most appropriate staging system and management strategies.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries